West Wealth Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
West Wealth Group's ABBV Position: Q3 2026 in Review
West Wealth Group sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 2,120 shares — an estimated $534K sold.
West Wealth Group first reported a position in ABBV in Q4 2021 and held it in 18 quarters. The position peaked at $534K in Q2 2026. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- West Wealth Group reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
- West Wealth Group sold 2,120 AbbVie shares in Q3 2026, an estimated $534K.
- West Wealth Group first reported a position in AbbVie in Q4 2021 and held it in 18 quarters.
- West Wealth Group's AbbVie position peaked at $534K in Q2 2026.
- 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on West Wealth Group's 13F filing for Q3 2026, filed 14 Oct 2026.